🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

QurAlis is proud to sponsor the 2025 Targetals Annual Meeting held last week to accelerate progress toward the development of new therapeutic approaches for #ALS, where Emma Bowden, QurAlis' SVP and head of development, was a featured speaker. Emma presented on QRL-101, QurAlis'

QurAlis Presents! QurAlis' CBO, Vikas Sharma, was a featured speaker at the #BIOEQUITYEUROPE 2025 conference held last week in Bruges, Belgium. BioEquity Europe is Europe's destination event for biopharma decision makers to network, partner, and debate critical issues facing the

QurAlis was honored to have Judson R., a person living with #ALS, come share his journey with our team. Judson talked about his diagnosis, the physical and emotional impact of ALS, and how humor and perspective help him throughout his journey. Judson and all who are living ALS

May is #PSPAwarenessMonth. QurAlis joins the global effort in spreading knowledge about #progressivesupranuclearpalsy (#PSP), fostering community support, and promoting research for a cure. PSP, often referred to as a "cousin" of #Parkinsonsdisease, is characterized by severe

QurAlis wishes everyone a meaningful and safe #MemorialDay as we remember and honor all who gave the ultimate sacrifice for our country.

QurAlis is proud to sponsor and attend the European Network to Cure #ALS (#ENCALS) 2025 Annual Meeting taking place June 3-6, 2025 hosted in Turin, Italy. ENCALS brings researchers and advocates together from Europe and around the world to share the latest research and advances

Love, respect, and unity for all! QurAlis is proud to celebrate #PrideMonth which emphasizes the importance of inclusivity and acceptance. Happy Pride!

QurAlis Presents! Hagen Cramer, QurAlis' chief technology officer, is a featured speaker at the International #Oligonucleotide and Peptides Conference taking place next week in Prague, Czech Republic. Hagen will deliver his presentation entitled, "Points to Consider When

June is Global #MND/#ALS Awareness Month. QurAlis joins the global MND/ALS community to recognize people living with MND/ALS around the world, honor those lost to this devastating #neurodegenerativedisease, and raise awareness about the important work underway toward discovering

#ENCALS25 is a wrap! It was wonderful to see friends and former colleagues, make new acquaintances, and participate in great scientific exchange as we all work toward making a meaningful difference in the lives of people with #ALS. #precisionmedicine #neurodegenerativediseases

QurAlis Presents! Emma Bowden, QurAlis' SVP and head of development presented a poster on our QRL-201 ANQUR clinical trial at #ENCALS25. QRL-201 is a first-in-class precision therapeutic product candidate that has the potential to restore STMN2 expression in #ALS patients with

QurAlis Presents! Samantha Rubino, dir. of clinical operations, presented a poster about QurAlis' clinical trial program for QRL-101 in #ALS patients. QRL-101 is a potentially best-in-class selective Kv7.2/7.3 ion channel opener for the treatment of hyperexcitability-induced

QurAlis Presents! Hagen Cramer, QurAlis' chief technology officer, was a featured speaker at the International #Oligonucleotide and Peptides Conference held last week where he presented, "Points to Consider When Preparing for Oligonucleotide-Based Regulatory Submissions."

In honor of Global #MND/#ALS Awareness Month, QurAlis team member Corey Straub volunteered at the ALS Quebec Walk to End ALS held this past weekend in Montreal. Thank you Corey for representing QurAlis at this important event in Canada to raise awareness about this devastating

QurAlis is excited to announce our new global headquarters in Cambridge, MA. Our new 30,000 sq.ft. state-of-the-art research facility and office space doubles QurAlis' footprint in the heart of Cambridge's vibrant Alewife Biotech Park. Jason Brown, QurAlis' CFO said,

QurAlis wishes all a meaningful and fulfilled #Juneteenth as we remember the struggles and celebrate the triumphs of those who fought for freedom, and work toward a brighter future. #FreedomDay

Check out this week's story on Good Morning America where Eric Dane shares his diagnosis and experience living with #ALS with Diane Sawyer. He talks about his journey and the hope he has from the groundbreaking work of his doctor, Merit cudkowicz. QurAlis is honored to have Dr. Cudkowicz as a

Tomorrow, June 21 is Global #MND/#ALS Awareness Day - a day to honor all living with and impacted by MND/ALS around the world and raise awareness about the important work underway toward discovering and developing new treatments and ultimately, an end to this devastating

July is #NationalFragileXAwarenessMonth, a time to honor those whose lives have been affected by Fragile X syndrome (#FXS). QurAlis joins the FXS community to raise disease awareness and advocate for research aimed at developing effective treatments and possibly even a cure for

QurAlis wishes all a happy, safe, and meaningful #july4th celebration. Happy birthday America! Happy #independenceday!